JOURNAL DESCRIPTION

The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.

Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.

Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.

The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.

Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.

The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.

Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.

The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.

Medical Radiology and Radiation Safety. 2019. Vol. 64. No. 1. P. 45–52

RADIATION THERAPY

DOI: 10.12737/article_5c55fb4a074ee1.27347494

Е.S. Sukhikh1,2, L.G. Sukhikh2, О.Yu. Anikeeva3, P.V. Izhevsky4, I.N. Sheino4

Dosimetric Evaluation for Various Methods of Combined Radiotherapy of Cervical Cancer

1. Tomsk Regional Oncology Center, Tomsk, Russian Federation. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. ;
2. National Research Tomsk Polytechnic University, Tomsk, Russia;
3. Medical and Rehabilitation Center, Moscow, Russia;
4. A.I. Burnasyan Federal Medical Biophysical Center, Moscow, Russia

Е.S. Sukhikh – Head of Dep., PhD Phys-Math.;
L.G. Sukhikh – Director, PhD Phys.-Math.;
О.U. Anikeeva – Head of Dep., Dr. Sci. Med.;
P.V. Izhevsky – Leading Researcher, PhD Med., Assistant Prof.;
I.N. Sheino – Head of the Lab., PhD Phys.-Math.

Abstract

Purpose: Carrying out dosimetric investigation of possibility to replace a traditional combined radiation therapy of cervical cancer by combinations only external irradiation, without change of total course dose and number of fractions.

Material and methods: Eleven patients with a diagnosis of cervical cancer (stages T2bNхM0 and T3NхM0) who received a course of combined radiotherapy (CRT) have been considered in this study. The combination of dose delivery techniques 3D-CRT + high dose rate brachytherapy (HDR) was used as a basic one. The following fractionation regimes for CRT were simulated: external beam RT (EBRT) of the first stage – total dose 50 Gy and fraction dose 2 Gy (25 fractions), the second stage – total dose 28 Gy and fraction dose 7 Gy (4 fractions). Total CRT course dose was 89.7 Gy EQD2. Dosimetric planning of EBRT using conventional radiography and 3D-CRT has been carried out using XIO dosimetry planning system. Dosimetric planning of first-stage EBRT and second-stage EBRT using the VMAT technique has been performed in the Monaco dosimetry planning system. HDR of the second stage has been planned using the HDRplus dosimetric planning system for the Multisource HDR unit with a 60Co source.

Results: Coverage of the clinical volume of the tumor using HDR, on average, was equal to 95 % of the prescribed dose at 91.8 % of the volume, 110 % of the dose – 75.7 % of the volume. 60Co + VMAT results in the coverage level 95 % of the dose at 97.1 % of the volume and 110 % of the dose at 2.1 % of the volume. 3D-CRT + VMAT provide the coverage level of 95 % of the dose at 98 % of the volume and 110 % of the dose at 2.6 % of the volume. Using the combination VMAT + VMAT allows achieving the average coverage of the target at the level of 98 % of the dose at 97 % of the volume, 110 % of the dose at 8.8 % of the volume. The maximum dose per volume of the organs at risk equal to 2 cm3 did not exceed their tolerant levels both for the bladder and for the rectum.

Conclusion: At present, there is a technical possibility to replace the second stage of CRT cervical cancer by EBRT using the VMAT technique. Implementation of the VMAT technique allows to increase the uniformity of irradiated volume coverage comparing with traditional HDR. While using VMAT technique the tolerant levels of organs at risk are not exceeded.

Key words: combined radiotherapy, brachytherapy, external beam radiation therapy, cervical cancer, dosimetric evaluation

REFERENCES

  1. Kravchenko GR, Zharov AV, Vazhenin AV, et al. Results of multicomponent treatment of patients with locally advanced forms of cervical cancer. Siberian Oncological Journal. 2009;33(3):20-3. (Russian).
  2. Kravets OA, Andreeva YuV, Kozlov OV, Nechushkin MI. Clinical and radiobiological planning of brachytherapy of locally advanced cervical cancer. Medical Physics. 2009;33(2):10-7. (Russian).
  3. A European study on MRI-guided brachytherapy in locally advanced cervical cancer EMBRACE Published 2009 [Internet] [cited 2018, April 02]. Available from: https://www.embracestudy.dk/UserUpload/PublicDocuments/EmbraceProtocol.pdf
  4. Hellebust TA, Kirisits C, Berger D. Recommendations for gynaecological (GYN) GEC ESTRO working group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol. 2010;96(2):153-60. DOI: 10.1016/j.radonc.2010.06.004.
  5. Bucci МК, Bevan A, Roach М. Advances in radiation therapy: conventional to 3D, to IMRT, to 4D and beyond. С A Cancer Clin. 2005 Mar-Apr;55(2):117-34. PubMed PMID: 15761080
  6. Kravets OA, Kozlov OV, Fedyanina AA, et al. Methodical aspects of contact radiation therapy of cervical cancer using 3d-planning. Medical Physics. 2017;73(1):16-24. (Russian).
  7. Roitberg GE, Usychkin SV, Boyko AV. Large-scale remote radiation therapy for prostate cancer. Medical Radiology and Radiation Safety. 2016;61(1):47-59. (Russian).
  8. Ghandour S, Matzinger O, Pachouda M. Volumetric-modulated arc therapy planning using multicriteria optimization for localized prostate cancer. J Appl Clin Med Phys. 2015;16(3):258-69. DOI: 10.1120/jacmp.v16i3.5410.
  9. Mahmoud O, Kilic K, Khan AJ, Beriwal S, Small W Jr. External beam techniques to boost cervical cancer when brachytherapy is not an option—theories and applications. Ann Transl Med. 2017;5(10):207-10. DOI: 10.21037/atm.2017.03.102. PubMed Central PMCID: PMC5451624. PubMed PMID: 28603722
  10. Dasu A, Dasu I. Prostate alpha/beta revisited – an analysis of clinical results from 14168 patients. Acta Oncologia. 2012;51(8):963-74. DOI: 10.3109/0284186X.2012.719635
  11. Brenner DJ, Hall EJ. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 1999;43(5):1095-101. PubMed PMID: 10192361
  12. Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):123-9. DOI: 10.1016/j.ijrobp.2009.03.078.
  13. Viswanathan AN, Yorke ED, Marks LB, Eifel PJ, Shipley WU. Radiation dose–volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys. 2010;76(3):116-22. DOI: 10.1016/j.ijrobp.2009.02.090.
  14. RTOG/EORTC Late Radiation Morbidity Scoring Schema [Internet] [cited 2018, March 03] Available from: https://www.rtog.org/Research Associates/Adverse Event Reporting/ RTOGEORTCLateRadiation Morbidity Scoring Schema.aspx
  15. Vishwanathan AN, Beriwal S, De Los Santos JF, et al. American Brachytherapy Society Consensus Guidelines for locally advanced carcinoma of the cervix. Part II: High-Dose-Rate Brachytherapy. Brachytherapy. 2012 Jan-Feb;11(1):47-52. DOI: 10.1016/j.brachy.2011.07.002.
  16. Gmurman VE. Theory of Probability and Mathematical Statistics. 9th ed. Moscow: High School. 2003. 479 p. (Russian).
  17. Wolfram Mathematica [Internet] Wolfram Research [cited 2018, April 02]. Available from: https://www.wolfram.com/mathematica

For citation: Sukhikh ЕS, Sukhikh LG, Anikeeva ОYu, Izhevsky PV, Sheino IN. Dosimetric Evaluation for Various Methods of Combined Radiotherapy of Cervical Cancer. Medical Radiology and Radiation Safety. 2019;64(1):45-52. (Russian).

DOI: 10.12737/article_5c55fb4a074ee1.27347494

PDF (RUS) Full-text article (in Russian)

Contact Information

 

46, Zhivopisnaya st., 123098, Moscow, Russia Phone: +7 (499) 190-95-51. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Journal location

Attendance

2768046
Today
Yesterday
This week
Last week
This month
Last month
For all time
992
2948
25438
25438
75789
75709
2768046

Forecast today
2112


Your IP:216.73.216.231